









Markets
/
Stocks
/
nasdaq-kymr
/

Kymera Therapeutics Inc

KYMR

43.096USD

+0.136+0.32%

Market hours （ET）Quotes delayed by 15 min

2.81BMarket Cap

LossP/E TTM



Kymera Therapeutics Inc

43.096

+0.136+0.32%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Total revenue

114.83%22.10M

-84.56%7.39M

-20.88%3.74M

55.33%25.65M

8.67%10.29M

196.70%47.88M

-50.50%4.73M

43.42%16.51M

-1.62%9.47M

5.66%16.14M

-53.03%9.55M

-37.83%11.51M

-48.55%9.62M

19.48%15.28M

39.93%20.34M

--18.52M

--18.70M

597.49%12.79M

1429.79%14.53M

--1.83M

--950.00K

Revenue

114.83%22.10M

-84.56%7.39M

-20.88%3.74M

55.33%25.65M

8.67%10.29M

196.70%47.88M

-50.50%4.73M

43.42%16.51M

-1.62%9.47M

5.66%16.14M

-53.03%9.55M

-37.83%11.51M

-48.55%9.62M

19.48%15.28M

39.93%20.34M

--18.52M

--18.70M

597.49%12.79M

1429.79%14.53M

--1.83M

--950.00K

Operating expenses

52.75%96.53M

31.18%88.15M

21.90%75.86M

27.85%76.58M

15.33%63.19M

22.69%67.20M

14.34%62.24M

14.47%59.90M

17.69%54.79M

11.16%54.77M

11.15%54.43M

20.98%52.32M

46.07%46.55M

92.71%49.27M

116.54%48.97M

--43.25M

--31.87M

87.77%25.57M

76.54%22.62M

--13.62M

--12.81M

R&D expenses

64.39%80.25M

35.58%71.82M

25.55%60.41M

29.36%59.20M

15.61%48.82M

22.81%52.97M

9.66%48.12M

10.83%45.77M

17.48%42.23M

14.93%43.13M

14.54%43.88M

17.24%41.29M

38.45%35.94M

84.04%37.53M

142.78%38.31M

--35.22M

--25.96M

83.94%20.39M

39.50%15.78M

--11.09M

--11.31M

Depreciation, depletion, and amortization

40.18%2.05M

39.34%1.99M

122.01%1.99M

115.33%1.94M

66.21%1.46M

69.56%1.43M

16.69%895.00K

27.66%900.00K

-9.79%879.00K

20.14%841.00K

9.57%767.00K

17.50%705.00K

94.88%974.40K

40.00%700.00K

--600.00K

--500.00K

38.50%500.00K

525.00%500.00K

--361.00K

--80.00K

Operating profit

-40.68%-74.43M

-318.16%-80.75M

-25.41%-72.12M

-17.38%-50.92M

-16.72%-52.91M

50.01%-19.31M

-28.13%-57.51M

-6.30%-43.38M

-22.72%-45.33M

-13.64%-38.63M

-56.73%-44.88M

-65.02%-40.81M

-180.45%-36.93M

-165.95%-33.99M

-254.29%-28.64M

---24.73M

---13.17M

-8.48%-12.78M

31.85%-8.08M

---11.78M

---11.86M

Net non-operating interest income (expenses)

Non-operating interest income

-4.51%8.92M

101.60%10.07M

107.07%9.70M

92.66%8.92M

109.81%9.34M

30.65%5.00M

144.03%4.68M

679.80%4.63M

1409.49%4.45M

2519.18%3.82M

1435.20%1.92M

506.12%594.00K

150.00%295.00K

17.74%146.00K

-0.79%125.00K

--98.00K

--118.00K

-58.67%124.00K

-71.69%126.00K

--300.00K

--445.00K

Non-operating interest expense

11.59%77.00K

32.69%69.00K

46.34%60.00K

27.08%61.00K

25.45%69.00K

-11.86%52.00K

5.13%41.00K

17.07%48.00K

19.57%55.00K

13.46%59.00K

-44.29%39.00K

46.43%41.00K

91.67%46.00K

92.59%52.00K

141.38%70.00K

--28.00K

--24.00K

-10.00%27.00K

625.00%29.00K

--30.00K

--4.00K

Special income (expenses)

100.00%0.00

--0.00

---4.92M

----

Income before tax

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

30.07%-7.99M

---11.51M

---11.42M

Income after tax

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

30.07%-7.99M

---11.51M

---11.42M

Net income from continuous operations

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

30.07%-7.99M

---11.51M

---11.42M

Net income attributable to controlling interests

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

30.07%-7.99M

---11.51M

---11.42M

Preferred share dividend

----

--0.00

----

Net income attributable to common shareholders

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.90%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

30.07%-7.99M

---11.51M

---11.42M

Basic earnings per share

-19.26%-0.82

-259.40%-0.88

9.29%-0.82

13.45%-0.58

2.46%-0.69

59.21%-0.25

-14.76%-0.90

14.45%-0.67

0.96%-0.70

8.69%-0.60

-39.91%-0.79

-42.19%-0.78

-142.53%-0.71

-131.14%-0.66

-213.68%-0.56

---0.55

---0.29

2.88%-0.29

30.07%-0.18

---0.29

---0.26

Diluted earnings per share

-19.26%-0.82

-259.40%-0.88

9.29%-0.82

13.45%-0.58

2.46%-0.69

59.21%-0.25

-14.76%-0.90

14.45%-0.67

0.96%-0.70

8.69%-0.60

-39.91%-0.79

-42.19%-0.78

-142.53%-0.71

-131.14%-0.66

-213.68%-0.56

---0.55

---0.29

2.88%-0.29

30.07%-0.18

---0.29

---0.26

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

